Drug Interactions between Elfabrio and sparsentan
This report displays the potential drug interactions for the following 2 drugs:
- Elfabrio (pegunigalsidase alfa)
- sparsentan
Interactions between your drugs
No interactions were found between Elfabrio and sparsentan. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Elfabrio
A total of 6 drugs are known to interact with Elfabrio.
- Elfabrio is in the drug class lysosomal enzymes.
- Elfabrio is used to treat Fabry Disease.
sparsentan
A total of 588 drugs are known to interact with sparsentan.
- Sparsentan is in the drug class miscellaneous cardiovascular agents.
- Sparsentan is used to treat Primary Immunoglobulin A Nephropathy.
Drug and food interactions
sparsentan food
Applies to: sparsentan
If you are taking sparsentan you should avoid potassium-containing salt substitutes or over-the-counter potassium supplements without first talking to your doctor. This can cause high levels of potassium in your blood. High levels of potassium can cause weakness, irregular heartbeat, confusion, tingling of the extremities, or feelings of heaviness in the legs. Call your doctor at once if you have any of these symptoms.
Consumption of grapefruit, grapefruit juice, and supplements that contain grapefruit should be avoided during treatment with sparsentan as they may increase the blood levels of sparsentan. This may increase the risk of side effects such as hepatotoxicity, acute kidney injury, hyperkalemia, edema, and hypotension.
Swallow sparsentan whole with water before your morning or evening meal. Take your dose with the same meal each day. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.